Skip to main content
Erschienen in: Pediatric Cardiology 3/2024

29.03.2023 | Research

Relationship of Left Ventricular Mass to Lean Body Mass in the Obese Pediatric Population

verfasst von: Susan M. Dusenbery, Sarah D. de Ferranti, Jason Kerstein, Michael Mendelson, Steven Colan, Kimberlee Gauvreau, Puneeta Arya

Erschienen in: Pediatric Cardiology | Ausgabe 3/2024

Einloggen, um Zugang zu erhalten

Abstract

Our primary aim was to investigate the relationship between LVM and anthropometric measures including lean body mass (LBM) in obese pediatric subjects compared to normal weight controls. A retrospective chart review identified subjects 2–18 years old who were normotensive and had normal echocardiograms between 1995 and 2020 at Boston Children’s Hospital. LVM was calculated with the 5/6 area length rule from 2D echocardiograms. LBM was calculated with equations derived from dual-energy X-ray absorptiometry. Of the 2217 subjects who met inclusion criteria, 203 were obese and 2014 had normal weight. The median age was 11.9 (2.0–18.9); 46% were female. The median LVM was 94.5 g (59.3–134.3) in obese subjects vs. 78.0 g (51.5–107.7) in controls. The median LBM was 37.2 kg (18.9–50.6) in obese subjects vs. 30.5 kg (17.6–40.8) in controls. In control and obese subjects, LBM had the strongest correlation to LVM (R2 0.86, P < 0.001) and (R2 0.87, P < 0.001), respectively. There was at most a modest correlation between tissue Doppler velocity z-scores and LV mass, and the largest was Septal E′ z-score in obese subjects (r = − 0.31, P = 0.006). In this cohort, LBM was found to have the strongest relationship to LVM in obese subjects. The largest correlation between tissue Doppler velocity z-scores and LV mass was Septal E′ z-score. Future studies will evaluate which measurements are more closely aligned with clinical outcomes in obese children.
Literatur
1.
Zurück zum Zitat Hampl SE et al (2023) Clinical practice guidelines for the evaluation and treatment of children and adolescents with obesity. Pediatrics 151(2):e2022060640CrossRefPubMed Hampl SE et al (2023) Clinical practice guidelines for the evaluation and treatment of children and adolescents with obesity. Pediatrics 151(2):e2022060640CrossRefPubMed
2.
Zurück zum Zitat Lauer MS, Anderson KM, Levy D (1992) Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 19(1):130–134CrossRefPubMed Lauer MS, Anderson KM, Levy D (1992) Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: the Framingham Heart Study. J Am Coll Cardiol 19(1):130–134CrossRefPubMed
3.
Zurück zum Zitat Li X et al (2004) Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation 110(22):3488–3492CrossRefPubMed Li X et al (2004) Childhood adiposity as a predictor of cardiac mass in adulthood: the Bogalusa Heart Study. Circulation 110(22):3488–3492CrossRefPubMed
4.
Zurück zum Zitat Cote AT et al (2013) Childhood obesity and cardiovascular dysfunction. J Am Coll Cardiol 62(15):1309–1319CrossRefPubMed Cote AT et al (2013) Childhood obesity and cardiovascular dysfunction. J Am Coll Cardiol 62(15):1309–1319CrossRefPubMed
5.
Zurück zum Zitat Zeybek C et al (2009) Right ventricular subclinical diastolic dysfunction in obese children: the effect of weight reduction with a low-carbohydrate diet. Pediatr Cardiol 30(7):946–953CrossRefPubMed Zeybek C et al (2009) Right ventricular subclinical diastolic dysfunction in obese children: the effect of weight reduction with a low-carbohydrate diet. Pediatr Cardiol 30(7):946–953CrossRefPubMed
6.
Zurück zum Zitat Mehta SK et al (2009) Abdominal obesity, waist circumference, body mass index, and echocardiographic measures in children and adolescents. Congenit Heart Dis 4(5):338–347CrossRefPubMed Mehta SK et al (2009) Abdominal obesity, waist circumference, body mass index, and echocardiographic measures in children and adolescents. Congenit Heart Dis 4(5):338–347CrossRefPubMed
7.
Zurück zum Zitat Peterson LR et al (2004) Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 43(8):1399–1404CrossRefPubMed Peterson LR et al (2004) Alterations in left ventricular structure and function in young healthy obese women: assessment by echocardiography and tissue Doppler imaging. J Am Coll Cardiol 43(8):1399–1404CrossRefPubMed
8.
Zurück zum Zitat Shea JR, Henshaw MH, Carter J, Chowdhury SM (2020) Lean body mass is the strongest anthropometric predictor of left ventricular mass in the obese paediatric population. Cardiol Young 30(4):476–481CrossRefPubMedPubMedCentral Shea JR, Henshaw MH, Carter J, Chowdhury SM (2020) Lean body mass is the strongest anthropometric predictor of left ventricular mass in the obese paediatric population. Cardiol Young 30(4):476–481CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Lang RM et al (2005) Recommendations for chamber quantification: a Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463CrossRefPubMed Lang RM et al (2005) Recommendations for chamber quantification: a Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440–1463CrossRefPubMed
10.
Zurück zum Zitat Foster BJ, Platt RW, Zemel BS (2012) Development and validation of a predictive equation for lean body mass in children and adolescents. Ann Hum Biol 39(3):171–182CrossRefPubMed Foster BJ, Platt RW, Zemel BS (2012) Development and validation of a predictive equation for lean body mass in children and adolescents. Ann Hum Biol 39(3):171–182CrossRefPubMed
11.
Zurück zum Zitat Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height–weight formula validated in infants, children, and adults. J Pediatr 93(1):62–66CrossRefPubMed Haycock GB, Schwartz GJ, Wisotsky DH (1978) Geometric method for measuring body surface area: a height–weight formula validated in infants, children, and adults. J Pediatr 93(1):62–66CrossRefPubMed
12.
Zurück zum Zitat Gradman AH et al (2006) From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48:326–341CrossRefPubMed Gradman AH et al (2006) From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48:326–341CrossRefPubMed
13.
Zurück zum Zitat Kenchaiah S et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313CrossRefPubMed Kenchaiah S et al (2002) Obesity and the risk of heart failure. N Engl J Med 347(5):305–313CrossRefPubMed
14.
Zurück zum Zitat Daniels SR et al (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76(10):699–701CrossRefPubMed Daniels SR et al (1995) Indexing left ventricular mass to account for differences in body size in children and adolescents without cardiovascular disease. Am J Cardiol 76(10):699–701CrossRefPubMed
15.
Zurück zum Zitat Foster BJ et al (2008) A novel method of expressing left ventricular mass relative to body size in children. Circulation 117(21):2769–2775CrossRefPubMed Foster BJ et al (2008) A novel method of expressing left ventricular mass relative to body size in children. Circulation 117(21):2769–2775CrossRefPubMed
16.
Zurück zum Zitat Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140(3):e20171904CrossRefPubMed Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, de Ferranti SD, Dionne JM, Falkner B, Flinn SK, Gidding SS, Goodwin C, Leu MG, Powers ME, Rea C, Samuels J, Simasek M, Thaker VV, Urbina EM (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140(3):e20171904CrossRefPubMed
17.
Zurück zum Zitat Foster BJ et al (2013) Limitations of expressing left ventricular mass relative to height and to body surface area in children. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 26(4):410–418CrossRef Foster BJ et al (2013) Limitations of expressing left ventricular mass relative to height and to body surface area in children. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr 26(4):410–418CrossRef
18.
Zurück zum Zitat Mahgerefteh J et al (2021) Height versus body surface area to normalize cardiovascular measurements in children using the Pediatric Heart Network echocardiographic Z-score database. Pediatr Cardiol 42:1284–1292CrossRefPubMedPubMedCentral Mahgerefteh J et al (2021) Height versus body surface area to normalize cardiovascular measurements in children using the Pediatric Heart Network echocardiographic Z-score database. Pediatr Cardiol 42:1284–1292CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Russo C et al (2011) Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 57:1368–1374CrossRefPubMedPubMedCentral Russo C et al (2011) Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. J Am Coll Cardiol 57:1368–1374CrossRefPubMedPubMedCentral
20.
21.
Zurück zum Zitat El Saiedi S (2018) Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a Tissue Doppler Imaging and Cardiac Troponin I Study. Cardiol Young 28:76–84CrossRefPubMed El Saiedi S (2018) Left ventricular diastolic dysfunction without left ventricular hypertrophy in obese children and adolescents: a Tissue Doppler Imaging and Cardiac Troponin I Study. Cardiol Young 28:76–84CrossRefPubMed
22.
Zurück zum Zitat Porcar-Almela M et al (2015) Left ventricular diastolic function and cardiometabolic factors in obese normotensive children. Nutr Metab Cardiovasc Dis 25(1):108–115CrossRefPubMed Porcar-Almela M et al (2015) Left ventricular diastolic function and cardiometabolic factors in obese normotensive children. Nutr Metab Cardiovasc Dis 25(1):108–115CrossRefPubMed
23.
Zurück zum Zitat Reis JP et al (2013) Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA 310:280–288CrossRefPubMedPubMedCentral Reis JP et al (2013) Association between duration of overall and abdominal obesity beginning in young adulthood and coronary artery calcification in middle age. JAMA 310:280–288CrossRefPubMedPubMedCentral
Metadaten
Titel
Relationship of Left Ventricular Mass to Lean Body Mass in the Obese Pediatric Population
verfasst von
Susan M. Dusenbery
Sarah D. de Ferranti
Jason Kerstein
Michael Mendelson
Steven Colan
Kimberlee Gauvreau
Puneeta Arya
Publikationsdatum
29.03.2023
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 3/2024
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-023-03133-w

Weitere Artikel der Ausgabe 3/2024

Pediatric Cardiology 3/2024 Zur Ausgabe

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.